Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tubulin Modulators | 11 | 2019 | 110 | 1.760 |
Why?
|
| Tubulin | 15 | 2019 | 695 | 1.600 |
Why?
|
| Drug Design | 11 | 2019 | 1078 | 1.270 |
Why?
|
| Fluorescent Dyes | 9 | 2023 | 1915 | 0.790 |
Why?
|
| Structure-Activity Relationship | 19 | 2019 | 3133 | 0.660 |
Why?
|
| Molecular Structure | 17 | 2019 | 1907 | 0.640 |
Why?
|
| Spectroscopy, Near-Infrared | 4 | 2023 | 721 | 0.620 |
Why?
|
| Erythromycin | 4 | 2016 | 120 | 0.600 |
Why?
|
| Contrast Media | 3 | 2023 | 5295 | 0.590 |
Why?
|
| Antineoplastic Agents | 17 | 2023 | 13655 | 0.580 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2017 | 77 | 0.570 |
Why?
|
| Bibenzyls | 4 | 2016 | 11 | 0.550 |
Why?
|
| Periodontal Pocket | 1 | 2015 | 166 | 0.520 |
Why?
|
| Bioreactors | 2 | 2015 | 236 | 0.500 |
Why?
|
| Microwaves | 3 | 2014 | 191 | 0.500 |
Why?
|
| Triazoles | 1 | 2019 | 907 | 0.470 |
Why?
|
| Drug Screening Assays, Antitumor | 12 | 2019 | 731 | 0.470 |
Why?
|
| Xanthine Oxidase | 3 | 2019 | 64 | 0.450 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1663 | 0.420 |
Why?
|
| Waste Disposal, Fluid | 1 | 2012 | 30 | 0.420 |
Why?
|
| Enzyme Inhibitors | 4 | 2019 | 3800 | 0.380 |
Why?
|
| Phosphorus | 1 | 2012 | 338 | 0.370 |
Why?
|
| Nitrogen | 1 | 2012 | 343 | 0.370 |
Why?
|
| Agaricales | 1 | 2010 | 29 | 0.370 |
Why?
|
| Monophenol Monooxygenase | 1 | 2010 | 69 | 0.370 |
Why?
|
| Polymerization | 6 | 2019 | 163 | 0.370 |
Why?
|
| Magnesium Compounds | 1 | 2009 | 3 | 0.360 |
Why?
|
| Salicylates | 1 | 2010 | 126 | 0.360 |
Why?
|
| Iodides | 1 | 2009 | 41 | 0.360 |
Why?
|
| Stilbenes | 3 | 2015 | 156 | 0.360 |
Why?
|
| Ethers | 1 | 2009 | 75 | 0.350 |
Why?
|
| Sodium Cyanide | 1 | 2008 | 8 | 0.340 |
Why?
|
| Formamides | 1 | 2008 | 20 | 0.340 |
Why?
|
| Cell Proliferation | 20 | 2019 | 10472 | 0.340 |
Why?
|
| Potassium Cyanide | 1 | 2008 | 16 | 0.340 |
Why?
|
| Water Pollutants, Chemical | 1 | 2012 | 311 | 0.310 |
Why?
|
| Esters | 1 | 2008 | 210 | 0.300 |
Why?
|
| Bone and Bones | 2 | 2015 | 2575 | 0.300 |
Why?
|
| Amines | 1 | 2008 | 278 | 0.290 |
Why?
|
| Biphenyl Compounds | 1 | 2010 | 914 | 0.270 |
Why?
|
| Proteome | 1 | 2015 | 1790 | 0.260 |
Why?
|
| Pyrazoles | 3 | 2019 | 1970 | 0.240 |
Why?
|
| Proteomics | 1 | 2015 | 3618 | 0.210 |
Why?
|
| Models, Molecular | 8 | 2019 | 5454 | 0.210 |
Why?
|
| Cyclobutanes | 1 | 2022 | 59 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2019 | 10943 | 0.200 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2014 | 623 | 0.190 |
Why?
|
| Biological Products | 1 | 2009 | 856 | 0.190 |
Why?
|
| Benzyl Compounds | 1 | 2019 | 21 | 0.180 |
Why?
|
| Cell Line, Tumor | 16 | 2019 | 16665 | 0.180 |
Why?
|
| Colchicine | 2 | 2018 | 242 | 0.180 |
Why?
|
| Oxadiazoles | 1 | 2019 | 93 | 0.170 |
Why?
|
| Models, Biological | 1 | 2015 | 9581 | 0.170 |
Why?
|
| Ionophores | 3 | 2023 | 108 | 0.160 |
Why?
|
| Tissue Distribution | 3 | 2023 | 2335 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13019 | 0.160 |
Why?
|
| Thiadiazines | 1 | 2017 | 10 | 0.160 |
Why?
|
| Quinoxalines | 1 | 2019 | 288 | 0.150 |
Why?
|
| Oxides | 1 | 2019 | 405 | 0.150 |
Why?
|
| Hydrazines | 1 | 2019 | 220 | 0.150 |
Why?
|
| Indoles | 2 | 2016 | 1834 | 0.150 |
Why?
|
| Sulfhydryl Compounds | 1 | 2018 | 296 | 0.140 |
Why?
|
| Binding Sites | 4 | 2019 | 6115 | 0.140 |
Why?
|
| Thiones | 1 | 2016 | 46 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 6313 | 0.140 |
Why?
|
| Campylobacter rectus | 1 | 2015 | 5 | 0.140 |
Why?
|
| Peritoneal Neoplasms | 1 | 2022 | 663 | 0.140 |
Why?
|
| Actinomyces | 1 | 2015 | 39 | 0.140 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 1181 | 0.130 |
Why?
|
| Maleic Anhydrides | 1 | 2014 | 8 | 0.130 |
Why?
|
| Ovarian Neoplasms | 2 | 2022 | 4823 | 0.130 |
Why?
|
| Organoselenium Compounds | 1 | 2014 | 22 | 0.130 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2016 | 282 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 1574 | 0.130 |
Why?
|
| Fasting | 1 | 2021 | 1589 | 0.120 |
Why?
|
| Maleimides | 1 | 2014 | 112 | 0.120 |
Why?
|
| Fusobacterium nucleatum | 1 | 2015 | 160 | 0.120 |
Why?
|
| Static Electricity | 1 | 2015 | 267 | 0.120 |
Why?
|
| Cytokinesis | 1 | 2015 | 177 | 0.120 |
Why?
|
| Organic Chemicals | 1 | 2015 | 211 | 0.120 |
Why?
|
| Carboxylic Acids | 1 | 2014 | 99 | 0.120 |
Why?
|
| Solvents | 1 | 2015 | 302 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 11039 | 0.120 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2015 | 407 | 0.120 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2019 | 642 | 0.110 |
Why?
|
| Databases, Protein | 1 | 2015 | 383 | 0.110 |
Why?
|
| Stereoisomerism | 3 | 2008 | 625 | 0.110 |
Why?
|
| HeLa Cells | 1 | 2019 | 3127 | 0.110 |
Why?
|
| Carbamates | 1 | 2014 | 195 | 0.110 |
Why?
|
| Thiazoles | 3 | 2017 | 1484 | 0.110 |
Why?
|
| Propanols | 1 | 2012 | 11 | 0.110 |
Why?
|
| Cycloparaffins | 1 | 2012 | 12 | 0.110 |
Why?
|
| Biological Oxygen Demand Analysis | 1 | 2012 | 4 | 0.110 |
Why?
|
| Electrolysis | 1 | 2012 | 9 | 0.110 |
Why?
|
| Animals | 14 | 2023 | 168561 | 0.110 |
Why?
|
| Aniline Compounds | 1 | 2017 | 983 | 0.100 |
Why?
|
| Aerobiosis | 1 | 2012 | 106 | 0.100 |
Why?
|
| Anaerobiosis | 1 | 2012 | 140 | 0.100 |
Why?
|
| Selenium | 1 | 2014 | 402 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1341 | 0.100 |
Why?
|
| Thiophenes | 1 | 2016 | 590 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1274 | 0.100 |
Why?
|
| Alkynes | 1 | 2012 | 306 | 0.100 |
Why?
|
| Biofilms | 1 | 2015 | 613 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 782 | 0.100 |
Why?
|
| Nanoparticles | 2 | 2019 | 1902 | 0.090 |
Why?
|
| Pyrazines | 1 | 2016 | 1231 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2015 | 3001 | 0.090 |
Why?
|
| Diphosphonates | 1 | 2015 | 625 | 0.090 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2009 | 23 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 1157 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 721 | 0.090 |
Why?
|
| Benzene | 1 | 2009 | 100 | 0.090 |
Why?
|
| Benzoxepins | 1 | 2008 | 1 | 0.090 |
Why?
|
| Benzimidazoles | 1 | 2014 | 848 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 944 | 0.080 |
Why?
|
| Neoplasms | 4 | 2023 | 21596 | 0.080 |
Why?
|
| Mice | 8 | 2023 | 81045 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2016 | 1057 | 0.080 |
Why?
|
| Esterification | 1 | 2007 | 36 | 0.080 |
Why?
|
| Flavones | 1 | 2007 | 66 | 0.080 |
Why?
|
| Kinetics | 2 | 2019 | 6474 | 0.080 |
Why?
|
| Isoflavones | 1 | 2008 | 139 | 0.080 |
Why?
|
| RANK Ligand | 1 | 2009 | 326 | 0.080 |
Why?
|
| Pyridines | 1 | 2018 | 2818 | 0.070 |
Why?
|
| Humans | 32 | 2023 | 742088 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 1477 | 0.070 |
Why?
|
| Methylation | 1 | 2009 | 1107 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2015 | 4211 | 0.070 |
Why?
|
| KB Cells | 2 | 2016 | 14 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2018 | 2933 | 0.070 |
Why?
|
| Calcinosis | 1 | 2015 | 1497 | 0.070 |
Why?
|
| Drug Delivery Systems | 3 | 2023 | 2217 | 0.060 |
Why?
|
| Kidney | 2 | 2019 | 7167 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2016 | 459 | 0.060 |
Why?
|
| Protein Structure, Quaternary | 2 | 2016 | 437 | 0.060 |
Why?
|
| Cell Cycle | 3 | 2019 | 2964 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2009 | 2500 | 0.060 |
Why?
|
| Biological Availability | 1 | 2023 | 396 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2016 | 5978 | 0.050 |
Why?
|
| Platinum | 1 | 2023 | 232 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 3843 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 7988 | 0.050 |
Why?
|
| Cattle | 2 | 2019 | 3923 | 0.050 |
Why?
|
| Cyclization | 2 | 2012 | 65 | 0.050 |
Why?
|
| Hypertension | 1 | 2021 | 8455 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 40450 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 2187 | 0.050 |
Why?
|
| Carboplatin | 1 | 2023 | 799 | 0.050 |
Why?
|
| Trifluoroacetic Acid | 1 | 2019 | 6 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 10163 | 0.050 |
Why?
|
| Protein Multimerization | 2 | 2016 | 971 | 0.050 |
Why?
|
| Sulfuric Acids | 1 | 2019 | 37 | 0.050 |
Why?
|
| Formates | 1 | 2019 | 43 | 0.050 |
Why?
|
| Oxygen | 1 | 2012 | 4169 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1788 | 0.040 |
Why?
|
| Asia | 1 | 2020 | 607 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2018 | 4013 | 0.040 |
Why?
|
| Skull | 1 | 2023 | 810 | 0.040 |
Why?
|
| Phenols | 1 | 2022 | 501 | 0.040 |
Why?
|
| Tetrazolium Salts | 2 | 2007 | 96 | 0.040 |
Why?
|
| Cisplatin | 1 | 2023 | 1637 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2007 | 1575 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2022 | 2552 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2019 | 699 | 0.040 |
Why?
|
| beta-Cyclodextrins | 1 | 2016 | 64 | 0.040 |
Why?
|
| Jurkat Cells | 2 | 2009 | 742 | 0.040 |
Why?
|
| Click Chemistry | 1 | 2016 | 95 | 0.030 |
Why?
|
| DNA Fragmentation | 1 | 2016 | 242 | 0.030 |
Why?
|
| Carbon | 1 | 2019 | 686 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 413 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2014 | 5975 | 0.030 |
Why?
|
| Ligation | 1 | 2016 | 453 | 0.030 |
Why?
|
| Models, Chemical | 1 | 2017 | 626 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 297 | 0.030 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2015 | 129 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3339 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 2014 | 249 | 0.030 |
Why?
|
| tau Proteins | 1 | 2023 | 1860 | 0.030 |
Why?
|
| Triglycerides | 1 | 2021 | 2450 | 0.030 |
Why?
|
| Ruthenium | 1 | 2012 | 22 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2016 | 692 | 0.030 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 1009 | 0.020 |
Why?
|
| Injections | 1 | 2014 | 840 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 1158 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4751 | 0.020 |
Why?
|
| Catalysis | 1 | 2012 | 760 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 9735 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2505 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3574 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3564 | 0.020 |
Why?
|
| Pyrroles | 1 | 2015 | 1143 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4391 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 7153 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3689 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 2203 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 3847 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2007 | 326 | 0.020 |
Why?
|
| Apoptosis | 2 | 2016 | 9715 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2021 | 6249 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2021 | 53187 | 0.020 |
Why?
|
| Male | 3 | 2021 | 349538 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 643 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 9387 | 0.020 |
Why?
|
| Female | 3 | 2022 | 379592 | 0.020 |
Why?
|
| Swine | 1 | 2014 | 5934 | 0.020 |
Why?
|
| Cell Separation | 1 | 2009 | 1749 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1782 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2699 | 0.010 |
Why?
|
| Software | 1 | 2015 | 4434 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2007 | 5180 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 5519 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4414 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 5872 | 0.010 |
Why?
|
| Risk Factors | 1 | 2021 | 72145 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 13029 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 19223 | 0.010 |
Why?
|
Concepts
(217)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_